Company record
Monogram Biosciences develops and manufactures diagnostic assays focused on HIV drug resistance and viral tropism. Its portfolio comprises genotypic and phenotypic resistance tests, a range of assay kits identified by test codes, viral load measurements, and associated therapeutic agents. The solutions are applied to the clinical management of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, various cancers, and additional viral diseases.
This directory record does not yet have a linked material-flow brief.